Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Neurosci ; 21(22): 8734-45, 2001 Nov 15.
Article in English | MEDLINE | ID: mdl-11698585

ABSTRACT

To study the role of mGlu7 receptors (mGluR7), we used homologous recombination to generate mice lacking this metabotropic receptor subtype (mGluR7(-/-)). After the serendipitous discovery of a sensory stimulus-evoked epileptic phenotype, we tested two convulsant drugs, pentylenetetrazole (PTZ) and bicuculline. In animals aged 12 weeks and older, subthreshold doses of these drugs induced seizures in mGluR7(-/-), but not in mGluR7(+/-), mice. PTZ-induced seizures were inhibited by three standard anticonvulsant drugs, but not by the group III selective mGluR agonist (R,S)-4-phosphonophenylglycine (PPG). Consistent with the lack of signs of epileptic activity in the absence of specific stimuli, mGluR7(-/-) mice showed no major changes in synaptic properties in two slice preparations. However, slightly increased excitability was evident in hippocampal slices. In addition, there was slower recovery from frequency facilitation in cortical slices, suggesting a role for mGluR7 as a frequency-dependent regulator in presynaptic terminals. Our findings suggest that mGluR7 receptors have a unique role in regulating neuronal excitability and that these receptors may be a novel target for the development of anticonvulsant drugs.


Subject(s)
Genetic Predisposition to Disease , Glycine/analogs & derivatives , Receptors, Metabotropic Glutamate/deficiency , Seizures/genetics , Animals , Anticonvulsants/pharmacology , Bicuculline , Cerebral Cortex/drug effects , Cerebral Cortex/physiopathology , Convulsants , Drug Resistance/genetics , Electroencephalography , Excitatory Amino Acid Agonists/pharmacology , Gene Targeting , Glycine/pharmacology , Hippocampus/drug effects , Hippocampus/physiopathology , Homozygote , In Vitro Techniques , Mice , Mice, Knockout , Pentylenetetrazole , Phenotype , Physical Chromosome Mapping , Receptors, Metabotropic Glutamate/genetics , Seizures/chemically induced , Seizures/physiopathology , Seizures/prevention & control
2.
Eur J Pharmacol ; 310(1): 61-6, 1996 Aug 22.
Article in English | MEDLINE | ID: mdl-8880068

ABSTRACT

(RS)-alpha-Methyl-4-phosphonophenylglycine (MPPG) and (S)-alpha-methyl-3-carboxyphenylalanine (M3CPA), two novel preferential antagonists of group III metabotropic glutamate (mGlu) receptors, antagonized the neuroprotective activity of L-2-amino-4-phosphono-butanoate (L-AP4) or L-serine-O-phosphate in mice cultured cortical cells exposed to a toxic pulse of N-methyl-D-aspartate. In contrast, MPPG did not influence the neuroprotective activity of the selective group II mGlu receptor agonist, (2S,1'R,2'R,3'R)-2-(2,3-dicarboxy-cyclopropyl) glycine (DCG-IV). These results indicate that activation of group III mGu receptors exerts neuroprotective activity against excitotoxic neuronal death. At least one of the two major group III mGlu receptor subtypes, i.e. mGlu4 receptor, is expressed by cultured cortical neurons, as shown by immunocytochemical analysis with specific polyclonal antibodies.


Subject(s)
Alanine/analogs & derivatives , Phenylalanine/analogs & derivatives , Alanine/drug effects , Alanine/pharmacology , Alanine/physiology , Animals , Cells, Cultured/metabolism , Cerebral Cortex/cytology , Cerebral Cortex/drug effects , Cerebral Cortex/physiology , Mice , N-Methylaspartate/toxicity , Nerve Degeneration/drug effects , Neurons/drug effects , Phenylalanine/drug effects , Phenylalanine/pharmacology , Phenylalanine/physiology , Rabbits , Receptors, Metabotropic Glutamate/antagonists & inhibitors , Receptors, Metabotropic Glutamate/drug effects , Receptors, Metabotropic Glutamate/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...